4,084
Views
0
CrossRef citations to date
0
Altmetric
Review

Monitoring Cytokine Profiles During Immunotherapy

&
Pages 799-816 | Published online: 22 Nov 2010

Bibliography

  • Clay TM , HobeikaAC, MoscaPJ, LyerlyHK, MorseMA: Assays for monitoring cellular immune responses to active immunotherapy of cancer.Clin. Cancer Res.7 , 1127–1135 (2001).
  • Hrouda D , BabanB, DunsmuirWD, KirbyRS, DalgleishAG: Immunotherapy of advanced prostate cancer: a Phase I/II trial using Mycobacterium vaccae(SRL172).Br. J. Urol.82 , 568–573 (1998).
  • Beachy SH , RepaskyEA: Using extracellular biomarkers for monitoring efficacy of therapeutics in cancer patients: an update.Cancer Immunol. Immunother.57 , 759–775 (2008).
  • Kim H , JinH, LeeS et al.: The effect of rush immunotherapy with house dust mite in the production of IL-5 and IFN-γ from the peripheral blood T cells of asthmatic children.J. Korean Med. Sci.24 , 392–397 (2009).
  • Minelli M , SchiavinoD, MuscaF et al.: Oral hyposensitization to nickel induces clinical improvement and a decrease in TH1 and TH2 cytokines in patients with systemic nickel allergy syndrome.Int. J. Immunopathol. Pharmacol.23 , 193–201 (2010).
  • Nieminen K , LaaksonenK, SavolainenJ: Three-year follow-up study of allergen-induced in vitro cytokine and signalling lymphocytic activation molecule mRNA responses in peripheral blood mononuclear cells of allergic rhinitis patients undergoing specific immunotherapy.Int. Arch. Allergy Immunol.150 , 370–376 (2009).
  • Barker JM , BarrigaKJ, YuL et al.: Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY).J. Clin. Endocrinol. Metab.89 , 3896–3902 (2004).
  • Verge CF , GiananiR, KawasakiE et al.: Number of autoantibodies (against insulin, GAD or ICA512/IA2) rather than particular autoantibody specificities determines risk of type I diabetes.J. Autoimmun.9 , 379–383 (1996).
  • Dhiman N , HaralambievaIH, VierkantRA et al.: Predominant inflammatory cytokine secretion pattern in response to two doses of live rubella vaccine in healthy vaccinees.Cytokine50 , 24–29 (2010).
  • Bernstein ED , GardnerEM, AbrutynE, GrossP, MuraskoDM: Cytokine production after influenza vaccination in a healthy elderly population.Vaccine16 , 1722–1731 (1998).
  • Hoos A , ParmianiG, HegeK et al.: A clinical development paradigm for cancer vaccines and related biologics.J. Immunother.30 , 1–15 (2007).
  • Millán O , UrtasunN, BrunetM: Biomarkers of the immunomodulatory effect of immunosuppressive drugs in transplant recipients.Transplant Rev. (Orlando)23 , 120–128 (2009).
  • Finnerty CC , JeschkeMG, HerndonDN et al.: Temporal cytokine profiles in severely burned patients: a comparison of adults and children.Mol. Med.14 , 553–560 (2008).
  • Krause SW , RotheG, GnadM, ReichleA, AndreesenR: Blood leukocyte subsets and cytokine profile after autologous peripheral blood stem cell transplantation.Ann. Hematol.82 , 628–636 (2003).
  • Svane IM , PedersenAE, JohansenJS et al.: Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers.Cancer Immunol. Immunother.56 , 1485–1499 (2007).
  • de Jager W , BourcierK, RijkersGT, PrakkenBJ, Seyfert-MargolisV: Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays.BMC Immunol.10 , 52 (2009).
  • van den Engel NK , WinterH, RüttingerD et al.: Characterization of immune responses in gastric cancer patients: a possible impact of H. pylori to polarize a tumor-specific type 1 response?Clin. Immunol.120 , 285–296 (2006).
  • Kyte JA , TrachselS, RisbergB et al.: Unconventional cytokine profiles and development of T cell memory in long-term survivors after cancer vaccination.Cancer Immunol. Immunother.58 , 1609–1626 (2009).
  • Suntharalingam G , PerryMR, WardS et al.: Cytokine storm in a Phase 1 trial of the anti-CD28 monoclonal antibody TGN1412.N. Engl. J. Med.355 , 1018–1028 (2006).
  • Singh M , BasuS, CamellC et al.: Selective expansion of memory CD4(+) T cells by mitogenic human CD28 generates inflammatory cytokines and regulatory T cells.Eur. J. Immunol.38 , 1522–1532 (2008).
  • van der Vliet HJJ , MollingJW, NishiN et al.: Polarization of Vα-24+ Vβ-11+ natural killer T cells of healthy volunteers and cancer patients using α-galactosylceramide-loaded and environmentally instructed dendritic cells.Cancer Res.63 , 4101–4106 (2003).
  • Veldhoen M , SeddonB: Empowering T helper 17 cells in autoimmunity.Nat. Med.16 , 166–168 (2010).
  • Veldhoen M : The role of T helper subsets in autoimmunity and allergy.Curr. Opin. Immunol.21 , 606–611 (2009).
  • Kijanka G , MurphyD: Protein arrays as tools for serum autoantibody marker discovery in cancer.J. Proteomics72 , 936–944 (2009).
  • Dehqanzada ZA , StorrerCE, HuemanMT et al.: Assessing serum cytokine profiles in breast cancer patients receiving a HER2/neu vaccine using Luminex technology.Oncol. Rep.17 , 687–694 (2007).
  • Quast S , ZhangW, ShiveC et al.: IL-2 absorption affects IFN-γ and IL-5, but not IL-4 producing memory T cells in double color cytokine ELISPOT assays.Cell. Immunol.237 , 28–36 (2005).
  • Precopio ML , BettsMR, ParrinoJ et al.: Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses.J. Exp. Med.204 , 1405–1416 (2007).
  • Soares AP , ScribaTJ, JosephS et al.: Bacillus Calmette–Guérin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles.J. Immunol.180 , 3569–3577 (2008).
  • Karlsson AC , MartinJN, YoungerSR et al.: Comparison of the ELISPOT and cytokine flow cytometry assays for the enumeration of antigen-specific T cells.J. Immunol. Methods283 , 141–153 (2003).
  • Whiteside TL , ZhaoY, TsukishiroT et al.: Enzyme-linked immunospot, cytokine flow cytometry, and tetramers in the detection of T-cell responses to a dendritic cell-based multipeptide vaccine in patients with melanoma.Clin. Cancer Res.9 , 641–649 (2003).
  • Liu Z , YuanX, LuoY et al.: Evaluating the effects of immunosuppressants on human immunity using cytokine profiles of whole blood.Cytokine45 , 141–147 (2009).
  • Burgdorf SK , ClaessonMH, NielsenHJ, RosenbergJ: Changes in cytokine and biomarker blood levels in patients with colorectal cancer during dendritic cell-based vaccination.Acta Oncol.48 , 1157–1164 (2009).
  • McElhaney JE , XieD, HagerWD et al.: T cell responses are better correlates of vaccine protection in the elderly.J. Immunol.176 , 6333–6339 (2006).
  • Betts MR , NasonMC, WestSM et al.: HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells.Blood107 , 4781–4789 (2006).
  • Darrah PA , PatelDT, De Luca PM et al.: Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat. Med.13 , 843–850 (2007).
  • Takahashi H , TsujiH, HashimotoY, Ishida-YamamotoA, IizukaH: Serum cytokines and growth factor levels in Japanese patients with psoriasis.Clin. Exp. Dermatol.35(6) , 645–649 (2009).
  • Dufour C , FerrettiE, BagnascoF et al.: Changes in cytokine profile pre- and post-immunosuppression in acquired aplastic anemia.Haematologica94 , 1743–1747 (2009).
  • Inagaki A , IshidaT, IshiiT et al.: Clinical significance of serum Th1-, Th2- and regulatory T cells-associated cytokines in adult T-cell leukemia/lymphoma: high interleukin-5 and -10 levels are significant unfavorable prognostic factors.Int. J. Cancer118 , 3054–3061 (2006).
  • Kimura A , SakuraiT, KoumuraA et al.: Longitudinal analysis of cytokines and chemokines in the cerebrospinal fluid of a patient with Neuro-Sweet disease presenting with recurrent encephalomeningitis.Intern. Med.47 , 135–141 (2008).
  • Christensen E , PintilieM, EvansKR et al.: Longitudinal cytokine expression during IMRT for prostate cancer and acute treatment toxicity.Clin. Cancer Res.15 , 5576–5583 (2009).
  • Khatri VP , FehnigerTA, BaiocchiRA et al.: Ultra low dose interleukin-2 therapy promotes a type 1 cytokine profile in vivo in patients with AIDS and AIDS-associated malignancies.J. Clin. Invest.101 , 1373–1378 (1998).
  • Zhang W , LiuS, CaoX et al.: A Phase-I clinical trial of active immunotherapy for acute leukemia using inactivated autologous leukemia cells mixed with IL-2, GM-CSF, and IL-6.Leuk. Res.29 , 3–9 (2005).
  • Tan AT , KohS, GohW et al.: A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B.J. Hepatol.52 , 330–339 (2010).
  • Hoge EA , BrandstetterK, MoshierS et al.: Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder.Depress. Anxiety26 , 447–455 (2009).
  • Casasnovas R , MounierN, BriceP et al.: Plasma cytokine and soluble receptor signature predicts outcome of patients with classical Hodgkin‘s lymphoma: a study from the Groupe d‘Etude des Lymphomes de l‘Adulte.J. Clin. Oncol.25 , 1732–1740 (2007).
  • Larsen CE , XuJ, LeeS et al.: Complex cytokine responses to hepatitis B surface antigen and tetanus toxoid in responders, nonresponders and subjects naive to hepatitis B surface antigen.Vaccine18 , 3021–3030 (2000).
  • Ovsyannikova IG , RyanJE, VierkantRA et al.: Influence of host genetic variation on rubella-specific T cell cytokine responses following rubella vaccination.Vaccine27 , 3359–3366 (2009).
  • Yuan J , GnjaticS, LiH et al.: CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit.Proc. Natl Acad. Sci. USA105 , 20410–20415 (2008).
  • Horton H , ThomasEP, StuckyJA et al.: Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination.J. Immunol. Methods323 , 39–54 (2007).
  • Comin-Anduix B , GualbertoA, GlaspyJA et al.: Definition of an immunologic response using the major histocompatibility complex tetramer and enzyme-linked immunospot assays.Clin. Cancer Res.12 , 107–116 (2006).
  • Nomura L , MainoVC, MaeckerHT: Standardization and optimization of multiparameter intracellular cytokine staining.Cytometry A73 , 984–991 (2008).
  • Maecker HT , RinfretA, D‘SouzaP et al.: Standardization of cytokine flow cytometry assays.BMC Immunol.6 , 13 (2005).
  • Britten CM , GouttefangeasC, WeltersMJP et al.: The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays.Cancer Immunol. Immunother.57 , 289–302 (2008).
  • Janetzki S , PanageasKS, Ben-PoratL et al.: Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI).Cancer Immunol. Immunother.57 , 303–315 (2008).
  • Janetzki S , BrittenCM, KalosM et al.: ‘MIATA‘-minimal information about T cell assays.Immunity31 , 527–528 (2009).
  • Hoffmeister B , BundeT, RudawskyIM, VolkH, KernF: Detection of antigen-specific T cells by cytokine flow cytometry: the use of whole blood may underestimate frequencies.Eur. J. Immunol.33 , 3484–3492 (2003).
  • Butterfield LH , DisisML, FoxBA et al.: A systematic approach to biomarker discovery; preamble to ‘the iSBTc-FDA taskforce on immunotherapy biomarkers‘.J. Transl. Med.6 , 81 (2008).
  • Carbone DP , CiernikIF, KelleyMJ et al.: Immunization with mutant p53- and K-ras-derived peptides in cancer patients: immune response and clinical outcome.J. Clin. Oncol.23 , 5099–5107 (2005).
  • Villacres MC , LongmateJ, AugeC, DiamondDJ: Predominant type 1 CMV-specific memory T-helper response in humans: evidence for gender differences in cytokine secretion.Hum. Immunol.65 , 476–485 (2004).
  • Sadeghi M , DanielV, NaujokatC et al.: Strong inflammatory cytokine response in male and strong anti-inflammatory response in female kidney transplant recipients with urinary tract infection.Transpl. Int.18 , 177–185 (2005).
  • Hahn AB , Kasten-JollyJC, ConstantinoDM et al.: TNF-α, IL-6, IFN-γ, and IL-10 gene expression polymorphisms and the IL-4 receptor α-chain variant Q576R: effects on renal allograft outcome.Transplantation72 , 660–665 (2001).
  • Shurin GV , YurkovetskyZR, ChattaGS et al.: Dynamic alteration of soluble serum biomarkers in healthy aging.Cytokine39 , 123–129 (2007).
  • Ovsyannikova IG , VierkantRA, PankratzVS et al.: HLA haplotype and supertype associations with cellular immune responses and cytokine production in healthy children after rubella vaccine.Vaccine27 , 3349–3358 (2009).
  • Gómez D , CorreaPA, GómezLM et al.: Th1/Th2 cytokines in patients with systemic lupus erythematosus: is tumor necrosis factor a protective?Semin. Arthritis Rheum.33 , 404–413 (2004).
  • Mazariegos GV , ReyesJ, WebberSA et al.: Cytokine gene polymorphisms in children successfully withdrawn from immunosuppression after liver transplantation.Transplantation73 , 1342–1345 (2002).
  • Pelletier R , PravicaV, PerreyC et al.: Evidence for a genetic predisposition towards acute rejection after kidney and simultaneous kidney–pancreas transplantation.Transplantation70 , 674–680 (2000).
  • Lee Y , ChoiH, LeeI, KimT, OhS: Association between IL-4R and TGF-β1 gene polymorphisms and the risk of colorectal cancer in a korean population.Colorectal Dis. DOI: 10.1111/j.1463-1318.2009.02080.x (2009) (Epub ahead of print).
  • Dhiman N , HaralambievaIH, KennedyRB et al.: SNP/haplotype associations in cytokine and cytokine receptor genes and immunity to rubella vaccine.Immunogenetics62 , 197–210 (2010).
  • Takahashi M , TerashimaM, TakaganeA et al.: Ghrelin and leptin levels in cachectic patients with cancer of the digestive organs.Int. J. Clin. Oncol.14 , 315–320 (2009).
  • Small EJ , SchellhammerPF, HiganoCS et al.: Placebo-controlled Phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer.J. Clin. Oncol.24 , 3089–3094 (2006).
  • Friedman EM , HayneyMS, LoveGD et al.: Social relationships, sleep quality, and interleukin-6 in aging women.Proc. Natl Acad. Sci. USA102 , 18757–18762 (2005).
  • Jiménez R , RamírezR, CarracedoJ et al.: Cytometric bead array (CBA) for the measurement of cytokines in urine and plasma of patients undergoing renal rejection.Cytokine32 , 45–50 (2005).
  • Copier J , WhelanM, DalgleishA: Biomarkers for the development of cancer vaccines: current status.Mol. Diagn. Ther.10 , 337–343 (2006).
  • Kalos M : An integrative paradigm to impart quality to correlative science.J. Transl. Med.8 , 26 (2010).
  • Walker EB , HaleyD, PetrauschU et al.: Phenotype and functional characterization of long-term gp100-specific memory CD8+ T cells in disease-free melanoma patients before and after boosting immunization.Clin. Cancer Res.14 , 5270–5283 (2008).
  • Tufte ER : Visual Explanations. Graphic Press LLC, Cheshire, CT, USA (1997).
  • Streeck H , BrummeZL, AnastarioM et al.: Antigen load and viral sequence diversification determine the functional profile of HIV-1-specific CD8+ T cells.PLoS Med.5 , e100 (2008).
  • Casazza JP , BettsMR, PriceDA et al.: Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation.J. Exp. Med.203 , 2865–2877 (2006).
  • Inokuma M , dela Rosa C, Schmitt C et al.: Functional T cell responses to tumor antigens in breast cancer patients have a distinct phenotype and cytokine signature. J. Immunol.179 , 2627–2633 (2007).
  • Siebert JC , InokumaM, WaidDM et al.: An analytical workflow for investigating cytokine profiles.Cytometry A73 , 289–298 (2008).
  • McKinney BA , ReifDM, RockMT et al.: Cytokine expression patterns associated with systemic adverse events following smallpox immunization.J. Infect. Dis.194 , 444–453 (2006).
  • van den Ham H , de Jager W, Bijlsma JWJ, Prakken BJ, de Boer RJ: Differential cytokine profiles in juvenile idiopathic arthritis subtypes revealed by cluster analysis. Rheumatology48 , 899–905 (2009).
  • Kattah MG , WongMT, YocumMD, UtzPJ: Cytokines secreted in response to Toll-like receptor ligand stimulation modulate differentiation of human Th17 cells.Arthritis Rheum.58 , 1619–1629 (2008).
  • Saeed AI , BhagabatiNK, BraistedJC et al.: TM4 microarray software suite.Meth. Enzymol.411 , 134–193 (2006).
  • Cruz JA , WishartDS: Applications of machine learning in cancer prediction and prognosis.Cancer Inform.2 , 59–77 (2006).
  • Michael A , BallG, QuatanN et al.: Delayed disease progression after allogeneic cell vaccination in hormone-resistant prostate cancer and correlation with immunologic variables.Clin. Cancer Res.11 , 4469–4478 (2005).
  • Doreau A , BelotA, BastidJ et al.: Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus.Nat. Immunol.10 , 778–785 (2009).
  • Evans CFM , GalustianC, Bodman-SmithM, DalgleishA, KumarD: The effect of colorectal cancer upon host peripheral immune cell function.Colorectal Dis.12 , 561–569 (2010).
  • Ohtani K , OhstukaY, IkuseT et al.: Increased mucosal expression of GATA-3 and STAT-4 in pediatric ulcerative colitis.Pediatr. Int.52(4) , 584–589 (2010).
  • Satyam A , SinghP, BadjatiaN, SethA, SharmaA: A disproportion of T(H)1/T(H)2 cytokines with predominance of T(H)2, in urothelial carcinoma of bladder.Urol. Oncol. DOI:10.1016/j.urolonc.2009.06.002 (2009) (Epub ahead of print).
  • Oliveira G , XavierP, MurphyB et al.: Cytokine analysis of human renal allograft aspiration biopsy cultures supernatants predicts acute rejection.Nephrol. Dial. Transplant.13 , 417–422 (1998).
  • Zisakis A , PiperiC, ThemistocleousMS et al.: Comparative analysis of peripheral and localised cytokine secretion in glioblastoma patients.Cytokine39 , 99–105 (2007).
  • Li H , WangC, YuJ et al.: Dendritic cell-activated cytokine-induced killer cells enhance the anti-tumor effect of chemotherapy on non-small cell lung cancer in patients after surgery.Cytotherapy11 , 1076–1083 (2010).
  • Soleimani A , BerntsenA, SvaneIM, PedersenAE: Immune responses in patients with metastatic renal cell carcinoma treated with dendritic cells pulsed with tumor lysate.Scand. J. Immunol.70 , 481–489 (2009).
  • Gitlitz BJ , BelldegrunAS, ZismanA et al.: A pilot trial of tumor lysate-loaded dendritic cells for the treatment of metastatic renal cell carcinoma.J. Immunother.26 , 412–419 (2003).
  • Leonhartsberger N , RamonerR, PutzT et al.: Antigen-independent immune responses after dendritic cell vaccination.Cancer Immunol. Immunother.56 , 897–903 (2007).
  • Ribas A , GlaspyJA, LeeY et al.: Role of dendritic cell phenotype, determinant spreading, and negative costimulatory blockade in dendritic cell-based melanoma immunotherapy.J. Immunother.27 , 354–367 (2004).
  • Bladon J , TaylorPC: Early reduction in number of T cells producing proinflammatory cytokines, observed after extracorporeal photopheresis, is not linked to apoptosis induction.Transplant. Proc.35 , 1328–1332 (2003).
  • Pukhalsky AL , ShmarinaGV, BliacherMS et al.: Cytokine profile after rubella vaccine inoculation: evidence of the immunosuppressive effect of vaccination.Mediators Inflamm.12 , 203–207 (2003).

▪ Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.